icon-folder.gif   Conference Reports for NATAP  
 
  14th European AiDS Conference
Oct 16-19 2013
Brussels, Belgium
Back grey_arrow_rt.gif
 
 
 
STaR Study: Single-Tablet Regimen Rilpivirine/Emtricitabine/Tenofovir DF Maintains Non-Inferiority to Efavirenz/Emtricitabine/Tenofovir DF in ART-Na´ve Adults Week 96 Results
 
 
  Reported by Jules Levin
14th European AIDS Conference
16-19 October, 2013
Brussels, Belgium
 
C Cohen1, D Wohl2, J Arribas3, K Henry4, J van Lunzen5, M Bloch6, W Towner7, E Wilkins8, R Ebrahimi9, D Porter9, K Patel9, S De-Oertel9, T Fralich9, B Guyer9 1Community Research Initiative of New England, Boston, Massachusetts USA; 2University of North Carolina at Chapel Hill, Chapel Hill, North Carolina USA; 3Hospital La Paz, Madrid, Spain; 4HIV Program Hennepin County Medical Center, Minneapolis, Minnesota, USA; 5University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 6Holdsworth House Medical Practice, Darlinghurst, NSW Australia; 7Department of Infectious Disease Kaiser Los Angeles Medical Center, Los Angeles, California, USA; 8North Manchester General Hospital, Manchester, United Kingdom; 9Gilead Sciences, Foster City, California, USA

EACS1.gif

EACS2.gif

EACS3.gif

EACS4.gif

EACS5.gif

EACS6.gif

EACS7.gif

EACS8.gif

EACS9.gif

EACS10.gif

EACS11.gif